Key result
Chronic parasympathetic stimulation via a cardiac neurostimulator effectively decreased ventricular rate during atrial fibrillation to 100-140 bpm over 1-2 years in dogs.
Why the study?
Does chronic parasympathetic stimulation of the right inferior ganglionated plexus reduce ventricular rate during atrial fibrillation in a canine model?
Does chronic parasympathetic stimulation of the right inferior ganglionated plexus reduce ventricular rate during atrial fibrillation in a canine model?
Chronic parasympathetic stimulation of the right inferior ganglionated plexus via a transvenous neurostimulator is a feasible and effective method for ventricular rate control during atrial fibrillation in a canine model.
Answers are grounded in this paper and cite their sources.
Provides long-term proof-of-concept in dogs; leaves open translation to human AF rate control.
INTRODUCTION: The right inferior ganglionated plexus (RIGP) selectively innervates the atrioventricular node. Temporary electrical stimulation of this plexus reduces the ventricular rate during atrial fibrillation (AF). We sought to assess the feasibility of chronic parasympathetic stimulation for ventricular rate control during AF with a nonthoracotomy intracardiac neurostimulation approach. METHODS AND RESULTS: In 9 mongrel dogs, the small endocardial area inside the right atrium, which overlies the RIGP, was identified by 20 Hz stimulation over a guiding catheter with integrated electrodes. Once identified, an active-fixation lead was implanted. The lead was connected to a subcutaneous neurostimulator. An additional dual-chamber pacemaker was implanted for AF induction by rapid atrial pacing and ventricular rate monitoring. Continuous neurostimulation was delivered for 1-2 years to decrease the ventricular rate during AF to a range of 100-140 bpm. Implantation of a neurostimulation lead was achieved within 37 +/- 12 min. The latency of the negative dromotropic response after on/offset or modulation of neurostimulation was <1 s. Continuous neurostimulation was effective and well tolerated during a 1-2 year follow-up with a stimulation voltage <5 V. The neurostimulation effect displayed a chronaxie-rheobase behavior (chronaxie time of 0.07 +/- 0.02 ms for a 50% decrease of the ventricular rate during AF). CONCLUSION: Chronic parasympathetic stimulation can be achieved via a cardiac neurostimulator. The approach is safe, effective, and well tolerated in the long term. The atrioventricular nodal selectivity and the opportunity to adjust the negative dromotropic effect within seconds may represent an advantage over pharmacological rate control.
No takes yet. Share an insight, caveat, or question.
Mischke et al. (2009) studied Atrial Fibrillation (n=9). Chronic parasympathetic stimulation via a cardiac neurostimulator was evaluated on Feasibility of chronic parasympathetic stimulation for ventricular rate control during AF. Chronic parasympathetic stimulation via a cardiac neurostimulator effectively decreased ventricular rate during atrial fibrillation to 100-140 bpm over 1-2 years in dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: